Endoscopic disinfection is a critical procedure in healthcare to ensure the safety of patients undergoing endoscopic examinations. This process involves meticulous cleaning and sterilization of endoscopes, medical instruments used for internal visualizations. Employing high-level disinfectants or sterilizing agents, the aim is to eliminate or minimize the presence of harmful microorganisms on endoscope surfaces. Comprehensive disinfection protocols encompass steps such as pre-cleaning, leak testing, high-level disinfection or sterilization, and proper drying. Strict adherence to these guidelines is paramount to prevent healthcare-associated infections and cross-contamination. Both manual and automated disinfection techniques are utilized, with the effectiveness of the procedure crucial for maintaining aseptic conditions. Proper storage of disinfected endoscopes in designated areas further contributes to ensuring the integrity of these instruments for diagnostic and therapeutic procedures. Continuous advancements in disinfection technologies, coupled with rigorous adherence to standardized protocols, play a pivotal role in upholding the highest standards of patient care and infection control in healthcare settings.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom